Pharmacom Labs Farestos 20mg

Pharmacom Labs Farestos 20mg | Toremifene Citrate Selective Estrogen Receptor Modulator

Pharmacom Labs Farestos is an orally active Selective Estrogen Receptor Modulator (SERM) delivering 20mg of Toremifene Citrate per unit dose. As a triphenylethylene derivative structurally related to tamoxifen, Toremifene Citrate exhibits tissue-specific estrogen receptor agonist and antagonist activity.

By competitively binding to nuclear estrogen receptors (ER-$\alpha$ and ER-$\beta$) in breast epithelial tissue without activation, Farestos blocks endogenous estradiol signaling. Simultaneously, its antagonistic action at the hypothalamic-pituitary level blocks negative estrogenic feedback, stimulating the pulsatile release of Gonadotropin-Releasing Hormone (GnRH), Luteinizing Hormone (LH), and Follicle-Stimulating Hormone (FSH) to support endogenous testosterone biosynthesis.

Manufactured by Pharmacom Labs under laboratory production standards, Farestos undergoes strict batch quality testing to ensure precise dosage uniformity and stability. Store at controlled room temperature (15°C to 25°C), shielded from direct light exposure, heat sources, and excess moisture.

Product Attribute Table